Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share (Details) - Schedule of Common Stock Equivalents

v3.24.3
Loss Per Share (Details) - Schedule of Common Stock Equivalents - shares
 3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 11,337,579 12,464,962
Convertible Notes [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 9,341,825 9,341,825
Options [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 1,995,754 3,123,137